Profit Or Loss [Abstract]

Marinomed Biotech AG - Filing #997033

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
11,276 EUR
11,628 EUR
Other income
8,376,000 EUR
1,575 EUR
Raw materials and consumables used
7,283 EUR
6,428 EUR
Employee benefits expense
4,849 EUR
4,462 EUR
Depreciation and amortisation expense
6,697,000 EUR
6,089,000 EUR
Other expenses, by nature
2,374 EUR
2,073 EUR
Profit (loss) from operating activities
4,914 EUR
4,145 EUR
Finance income
1,194 EUR
0 EUR
Finance costs
2,672 EUR
1,550 EUR
Profit (loss) before tax
6,391 EUR
5,694 EUR
Tax expense (income)
68,000 EUR
1,971,000 EUR
Profit (loss)
- EUR
- EUR
6,398 EUR
6,398 EUR
- EUR
- EUR
5,891 EUR
5,891 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
43,000
40,000
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
43,000
40,000

Talk to a Data Expert

Have a question? We'll get back to you promptly.